|
KR100361933B1
(ko)
|
1993-09-08 |
2003-02-14 |
라 졸라 파마슈티칼 컴파니 |
화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
|
|
US6057287A
(en)
|
1994-01-11 |
2000-05-02 |
Dyax Corp. |
Kallikrein-binding "Kunitz domain" proteins and analogues thereof
|
|
US7883693B2
(en)
*
|
1995-12-18 |
2011-02-08 |
Angiodevice International Gmbh |
Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
|
|
EP1221975B1
(de)
|
1999-10-04 |
2006-12-06 |
Nektar Therapeutics Al, Corporation |
Polymer-stabilisierte neuropeptide
|
|
US7074878B1
(en)
*
|
1999-12-10 |
2006-07-11 |
Harris J Milton |
Hydrolytically degradable polymers and hydrogels made therefrom
|
|
US6413507B1
(en)
*
|
1999-12-23 |
2002-07-02 |
Shearwater Corporation |
Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
|
|
CA2414076A1
(en)
|
2000-06-08 |
2001-12-13 |
La Jolla Pharmaceutical Company |
Multivalent platform molecules comprising high molecular weight polyethylene oxide
|
|
US7053150B2
(en)
|
2000-12-18 |
2006-05-30 |
Nektar Therapeutics Al, Corporation |
Segmented polymers and their conjugates
|
|
US7091186B2
(en)
|
2001-09-24 |
2006-08-15 |
Seattle Genetics, Inc. |
p-Amidobenzylethers in drug delivery agents
|
|
US7056500B2
(en)
|
2001-10-18 |
2006-06-06 |
Nektar Therapeutics Al, Corporation |
Polymer conjugates of opioid antagonists
|
|
US7482018B2
(en)
|
2001-12-21 |
2009-01-27 |
Soane Family Trust |
Use of oligomers and polymers for drug solubilization, stabilization, and delivery
|
|
PT3025726T
(pt)
*
|
2002-01-18 |
2020-01-09 |
Biogen Ma Inc |
Compostos do polímero polialquileno e utilizações dos mesmos
|
|
US7153829B2
(en)
|
2002-06-07 |
2006-12-26 |
Dyax Corp. |
Kallikrein-inhibitor therapies
|
|
PT2298278E
(pt)
|
2002-06-07 |
2016-02-25 |
Dyax Corp |
Prevenção e redução da perda de sangue e resposta inflamatória
|
|
SE0201874D0
(sv)
*
|
2002-06-19 |
2002-06-19 |
Biosensor Applications Sweden Ab Publ |
Coated metal surface on solid support for displacement reactions
|
|
GB0218827D0
(en)
*
|
2002-08-13 |
2002-09-18 |
Syngenix Ltd |
Anaesthetic compounds and conjugates thereof
|
|
US7632866B2
(en)
|
2002-10-21 |
2009-12-15 |
Ramot At Tel Aviv University |
Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators
|
|
EP1553932A2
(de)
*
|
2002-10-21 |
2005-07-20 |
Ramot at Tel Aviv University Ltd. |
N-phenylanthranilsäurederivate und 2-benzimidazolon-derivate als kalium-kanal und/oder kortikale neuronale aktivität modulatoren
|
|
US20040152769A1
(en)
*
|
2002-11-09 |
2004-08-05 |
Ekwuribe Nnochiri Nkem |
Modified carbamate-containing prodrugs and methods of synthesizing same
|
|
US7553930B2
(en)
*
|
2003-01-06 |
2009-06-30 |
Xencor, Inc. |
BAFF variants and methods thereof
|
|
US20050130892A1
(en)
*
|
2003-03-07 |
2005-06-16 |
Xencor, Inc. |
BAFF variants and methods thereof
|
|
US20050221443A1
(en)
*
|
2003-01-06 |
2005-10-06 |
Xencor, Inc. |
Tumor necrosis factor super family agonists
|
|
US7910661B2
(en)
|
2003-01-06 |
2011-03-22 |
Nektar Therapeutics |
Thiol-selective water-soluble polymer derivatives
|
|
US20060014248A1
(en)
*
|
2003-01-06 |
2006-01-19 |
Xencor, Inc. |
TNF super family members with altered immunogenicity
|
|
JP4789618B2
(ja)
*
|
2003-02-24 |
2011-10-12 |
株式会社Nrlファーマ |
新規転写因子、その製法および用途
|
|
US20060104968A1
(en)
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
|
US7871607B2
(en)
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
|
US20090123367A1
(en)
*
|
2003-03-05 |
2009-05-14 |
Delfmems |
Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases
|
|
EP2330213A1
(de)
|
2003-03-05 |
2011-06-08 |
Halozyme, Inc. |
Lösliches Hyaluronidaseglykoprotein (sHASEGP), Verfahren zu dessen Herstellung, Verwendungen und pharmazeutische Zusammensetzunge, die dieses umfassen
|
|
US7610156B2
(en)
*
|
2003-03-31 |
2009-10-27 |
Xencor, Inc. |
Methods for rational pegylation of proteins
|
|
US7587286B2
(en)
*
|
2003-03-31 |
2009-09-08 |
Xencor, Inc. |
Methods for rational pegylation of proteins
|
|
US7642340B2
(en)
|
2003-03-31 |
2010-01-05 |
Xencor, Inc. |
PEGylated TNF-α variant proteins
|
|
JP5628467B2
(ja)
|
2003-06-26 |
2014-11-19 |
シヴィダ・ユーエス・インコーポレイテッドPsivida Us, Inc. |
生体分解性徐放性ドラッグデリバリーシステム
|
|
ATE410186T1
(de)
|
2003-06-26 |
2008-10-15 |
Control Delivery Sys Inc |
In-situ gelierendes arzneimittelabgabesystem
|
|
JP5189765B2
(ja)
*
|
2003-08-01 |
2013-04-24 |
バイオコン・リミテッド |
加水分解可能なプロドラッグのためのアリールカルバメートオリゴマーおよびこれを含むプロドラッグ
|
|
CA3050564A1
(en)
*
|
2003-08-29 |
2005-03-10 |
Dyax Corp. |
Poly-pegylated protease inhibitors
|
|
EP1675871A2
(de)
|
2003-10-10 |
2006-07-05 |
Xencor Inc. |
Tnf-alpha-varianten auf proteinbasis zur behandlung von erkrankungen in verbindung mit tnf-alpha
|
|
WO2005047245A2
(en)
*
|
2003-11-14 |
2005-05-26 |
Wisconsin Alumni Research Foundation |
Fluorescence assays with improved blocking groups
|
|
US20060182692A1
(en)
|
2003-12-16 |
2006-08-17 |
Fishburn C S |
Chemically modified small molecules
|
|
CN1925875A
(zh)
|
2003-12-16 |
2007-03-07 |
尼克塔治疗亚拉巴马公司 |
化学改性的小分子
|
|
BRPI0507169A
(pt)
*
|
2004-02-02 |
2007-06-26 |
Ambrx Inc |
polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
|
|
EP1725262B1
(de)
*
|
2004-03-15 |
2021-05-26 |
Nektar Therapeutics |
Polymerische Zusammensetzungen und Konjugate von HIV-Entry-Inhibitoren
|
|
EP1771205B1
(de)
|
2004-06-18 |
2016-10-26 |
Ambrx, Inc. |
Neuartige antigen-bindende polypeptide und ihre verwendungen
|
|
JP2008506703A
(ja)
|
2004-07-14 |
2008-03-06 |
ユニバーシティ オブ ユタ リサーチ ファウンデーション |
ネトリン関連化合物および用途
|
|
JP2008507280A
(ja)
*
|
2004-07-21 |
2008-03-13 |
アンブレツクス・インコーポレイテツド |
非天然コードアミノ酸を用いた生合成ポリペプチド
|
|
US7235530B2
(en)
|
2004-09-27 |
2007-06-26 |
Dyax Corporation |
Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
|
|
US7612153B2
(en)
*
|
2004-10-25 |
2009-11-03 |
Intezyne Technologies, Inc. |
Heterobifunctional poly(ethylene glycol) and uses thereof
|
|
BRPI0519170A8
(pt)
|
2004-12-22 |
2018-05-08 |
Ambrx Inc |
formulações de hormônio de crescimento humano que compreendem um aminoácido não naturalmente codificado
|
|
CA2594557C
(en)
|
2004-12-22 |
2016-04-26 |
Ambrx, Inc. |
Modified human growth hormone
|
|
JP4990792B2
(ja)
|
2004-12-22 |
2012-08-01 |
アンブレツクス・インコーポレイテツド |
アミノアシル−tRNAシンテターゼの組成物およびこの使用
|
|
JP2008525032A
(ja)
|
2004-12-22 |
2008-07-17 |
アンブレツクス・インコーポレイテツド |
組換えヒト成長ホルモンを発現及び精製するための方法
|
|
US7517914B2
(en)
|
2005-04-04 |
2009-04-14 |
Boston Scientificscimed, Inc. |
Controlled degradation materials for therapeutic agent delivery
|
|
US8273339B2
(en)
*
|
2005-04-12 |
2012-09-25 |
Nektar Therapeutics |
Polymer-based compositions and conjugates of antimicrobial agents
|
|
SI1881850T1
(sl)
|
2005-05-13 |
2011-01-31 |
Lilly Co Eli |
Glp-1 pegilirane spojine
|
|
US20060263328A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Sang Van |
Hydrophilic polymers with pendant functional groups and method thereof
|
|
KR20080026135A
(ko)
|
2005-06-03 |
2008-03-24 |
암브룩스, 인코포레이티드 |
개선된 인간 인터페론 분자 및 이의 용도
|
|
CA2611823C
(en)
|
2005-06-16 |
2013-07-30 |
Nektar Therapeutics Al, Corporation |
Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
|
|
US8728493B2
(en)
*
|
2005-06-17 |
2014-05-20 |
Nektar Therapeutics |
Polymer based compositions and conjugates of non-steroidal anti-inflammatory drugs
|
|
FR2887883B1
(fr)
|
2005-06-29 |
2007-08-31 |
Lab Francais Du Fractionnement |
Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
|
|
AU2006275473B2
(en)
*
|
2005-07-29 |
2012-07-05 |
Nektar Therapeutics |
Methods for preparing carbonate esters of poly(ethylene glycol)
|
|
EP1951890A4
(de)
|
2005-11-16 |
2009-06-24 |
Ambrx Inc |
Verfahren und zusammensetzungen mit nichtnatürlichen aminosäuren
|
|
EP2319542B1
(de)
|
2006-02-21 |
2018-03-21 |
Nektar Therapeutics |
Segmentierte abbaubare Polymere und daraus hergestellte Konjugate
|
|
GB0604187D0
(en)
*
|
2006-03-02 |
2006-04-12 |
Fusion Antibodies Ltd |
Peptide and uses thereof
|
|
US7645860B2
(en)
|
2006-03-31 |
2010-01-12 |
Baxter Healthcare S.A. |
Factor VIII polymer conjugates
|
|
EP2007804B1
(de)
|
2006-04-20 |
2014-06-18 |
Amgen, Inc |
Glp-1-verbindungen
|
|
US7560588B2
(en)
|
2006-04-27 |
2009-07-14 |
Intezyne Technologies, Inc. |
Poly(ethylene glycol) containing chemically disparate endgroups
|
|
GB0611405D0
(en)
*
|
2006-06-09 |
2006-07-19 |
Univ Belfast |
FKBP-L: A novel inhibitor of angiogenesis
|
|
US8268948B2
(en)
*
|
2006-07-21 |
2012-09-18 |
Nektar Therapeutics |
Polymeric reagents comprising a terminal vinylic group and conjugates formed therefrom
|
|
CN101511856B
(zh)
|
2006-09-08 |
2016-01-20 |
Ambrx公司 |
脊椎动物细胞中抑制因子trna的转录
|
|
KR20090060294A
(ko)
*
|
2006-09-08 |
2009-06-11 |
암브룩스, 인코포레이티드 |
변형된 인간 혈장 폴리펩티드 또는 Fc 스캐폴드 및 그의 용도
|
|
MX2009007145A
(es)
|
2006-12-27 |
2009-08-27 |
Nektar Therapeutics Al Corp |
Conjugados de polimero con factor viii y factor de von willebrand que tienen una ligadura liberable.
|
|
WO2008082613A2
(en)
*
|
2006-12-27 |
2008-07-10 |
Nektar Therapeutics Al, Corporation |
Factor ix moiety-polymer conjugates having a releasable linkage
|
|
WO2008088983A1
(en)
|
2007-01-18 |
2008-07-24 |
Eli Lilly And Company |
PEGYLATED Aβ FAB
|
|
WO2008116913A2
(en)
*
|
2007-03-28 |
2008-10-02 |
Novo Nordisk A/S |
Peptide compounds with transient biodegradable pegylation
|
|
CA2682147C
(en)
|
2007-03-30 |
2017-08-08 |
Ambrx, Inc. |
Modified fgf-21 polypeptides and their uses
|
|
CN101675071B
(zh)
*
|
2007-05-02 |
2014-06-18 |
Ambrx公司 |
经修饰干扰素β多肽和其用途
|
|
WO2009026334A2
(en)
*
|
2007-08-21 |
2009-02-26 |
Genzyme Corporation |
Treatment with kallikrein inhibitors
|
|
WO2009037707A2
(en)
|
2007-09-20 |
2009-03-26 |
Ramot At Tel Aviv University Ltd. |
N-phenyl anthranilic acid derivatives and uses thereof
|
|
US20100303753A1
(en)
*
|
2007-10-19 |
2010-12-02 |
Nektar Therapeutics |
Oligomer Conjugates of Lidocaine and Its Derivatives
|
|
AU2008323768A1
(en)
*
|
2007-11-09 |
2009-05-14 |
Baxter Healthcare S.A. |
Modified recombinant Factor VIII and von Willebrand Factor and methods of use
|
|
CA2703830A1
(en)
|
2007-11-20 |
2009-05-28 |
Ambrx, Inc. |
Modified insulin polypeptides and their uses
|
|
EP2067494A1
(de)
|
2007-12-04 |
2009-06-10 |
Charité-Universitätsmedizin Berlin |
Blech oder röhrenförmige Struktur aus elastischem biokompatiblem Material und deren Verwendung
|
|
SG188143A1
(en)
|
2008-02-08 |
2013-03-28 |
Ambrx Inc |
Modified leptin polypeptides and their uses
|
|
KR100968280B1
(ko)
*
|
2008-02-13 |
2010-07-06 |
가자마 이엔티 (주) |
이비인후과용 의료장치
|
|
TWI395593B
(zh)
|
2008-03-06 |
2013-05-11 |
Halozyme Inc |
可活化的基質降解酵素之活體內暫時性控制
|
|
EP2271699A1
(de)
*
|
2008-03-14 |
2011-01-12 |
Egen, Inc. |
Biologisch abbaubare vernetzte verzweigte poly(alkylenimine)
|
|
WO2009128917A2
(en)
|
2008-04-14 |
2009-10-22 |
Halozyme, Inc. |
Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
|
|
TWI394580B
(zh)
|
2008-04-28 |
2013-05-01 |
Halozyme Inc |
超快起作用胰島素組成物
|
|
CA3004716C
(en)
|
2008-04-29 |
2022-04-12 |
Ascendis Pharma Endocrinology Division A/S |
Pegylated recombinant human growth hormone compounds
|
|
EP2318029B1
(de)
|
2008-07-23 |
2017-11-01 |
Ambrx, Inc. |
Modifizierte bovine g-csf-polypeptide und ihre verwendung
|
|
WO2010014258A2
(en)
*
|
2008-08-01 |
2010-02-04 |
Nektar Therapeutics Al, Corporation |
Conjugates having a releasable linkage
|
|
KR101660059B1
(ko)
|
2008-08-22 |
2016-09-26 |
박스알타 인코퍼레이티드 |
중합체 벤질 카르보네이트-유도체
|
|
US20110171164A1
(en)
*
|
2008-09-19 |
2011-07-14 |
Nektar Therapeutics |
Polymer conjugates of glp-2-like peptides
|
|
AU2009292651A1
(en)
*
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Polymer conjugates of AOD-like peptides
|
|
EP2340047A1
(de)
*
|
2008-09-19 |
2011-07-06 |
Nektar Therapeutics |
Polymerkonjugate von kiss1-peptiden
|
|
EP2344200A2
(de)
*
|
2008-09-19 |
2011-07-20 |
Nektar Therapeutics |
Modifizierte therapeutische peptide, herstellungsverfahren und verwendung
|
|
US20110171162A1
(en)
*
|
2008-09-19 |
2011-07-14 |
Nektar Therapeutics |
Polymer conjugates of thymosin alpha 1 peptides
|
|
US20110165113A1
(en)
*
|
2008-09-19 |
2011-07-07 |
Nektar Therapeutics |
Polymer conjugates of v681-like peptides
|
|
EP2340046A2
(de)
*
|
2008-09-19 |
2011-07-06 |
Nektar Therapeutics |
Polymerkonjugate von ziconotid-peptiden
|
|
EP2350118B1
(de)
*
|
2008-09-19 |
2016-03-30 |
Nektar Therapeutics |
Kohlenhydratbasisierte polymere zur wirkstoffabgabe und konjugate davon
|
|
US20110206633A1
(en)
*
|
2008-09-19 |
2011-08-25 |
Nektar Therapectics |
Polymer conjugates of cd-np peptides
|
|
US20110171166A1
(en)
*
|
2008-09-19 |
2011-07-14 |
Nektar Therapeutics |
Polymer conjugates of osteocalcin peptides
|
|
EP2340045B1
(de)
|
2008-09-19 |
2017-04-12 |
Nektar Therapeutics |
Polymerkonjugate aus protegrin-peptiden
|
|
WO2010033223A1
(en)
*
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Polymer conjugates of opioid growth factor peptides
|
|
WO2010033204A2
(en)
*
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Polymer conjugates of c-peptides
|
|
PE20110480A1
(es)
|
2008-09-26 |
2011-07-01 |
Ambrx Inc |
Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales
|
|
US8278418B2
(en)
|
2008-09-26 |
2012-10-02 |
Ambrx, Inc. |
Modified animal erythropoietin polypeptides and their uses
|
|
AU2009303368B2
(en)
|
2008-10-15 |
2012-04-05 |
Takeda Pharmaceutical Company Limited |
Pegylation of recombinant blood coagulation factors in the presence of bound antibodies
|
|
WO2010067378A2
(en)
|
2008-12-08 |
2010-06-17 |
Reliance Life Sciences Pvt. Ltd. |
Hydrogel composition
|
|
CN102307993B
(zh)
|
2008-12-09 |
2014-06-25 |
哈洛齐梅公司 |
延长的可溶性ph20多肽及其用途
|
|
JP2013516389A
(ja)
|
2009-01-06 |
2013-05-13 |
ダイアックス コーポレーション |
カリクレイン阻害剤による粘膜炎治療
|
|
US8633022B2
(en)
*
|
2009-02-24 |
2014-01-21 |
The Ritsumeikan Trust |
Dual-terminal amide hydrogelling agent
|
|
RU2744370C2
(ru)
|
2009-07-27 |
2021-03-05 |
Баксалта Инкорпорейтед |
Конъюгаты белков свертывания крови
|
|
BR112012001814A8
(pt)
|
2009-07-27 |
2018-02-06 |
Baxalta GmbH |
Conjugados de proteína de coagulação sanguínea
|
|
LT2459220T
(lt)
|
2009-07-31 |
2020-12-28 |
Ascendis Pharma A/S |
Biologiškai suyrantys vandenyje netirpūs hidrogeliai polietilenglikolio pagrindu
|
|
DK2459171T3
(en)
|
2009-07-31 |
2017-09-25 |
Sanofi Aventis Deutschland |
Long-acting insulin composition
|
|
KR20120089843A
(ko)
|
2009-07-31 |
2012-08-14 |
사노피-아벤티스 도이칠란트 게엠베하 |
인슐린 링커 접합체를 포함한 프로드럭
|
|
PT2477603E
(pt)
|
2009-09-17 |
2016-06-16 |
Baxalta Inc |
Co-formulação estável de hialuronidase e imunoglobulina e métodos para a sua utilização
|
|
AU2010314994B2
(en)
|
2009-11-09 |
2016-10-06 |
Spotlight Technology Partners Llc |
Fragmented hydrogels
|
|
JP5864429B2
(ja)
|
2009-11-09 |
2016-02-17 |
スポットライト テクノロジー パートナーズ エルエルシーSpotlight Technology Partners Llc |
架橋ヒドロゲル組成物、ヒドロゲル組成物の形成方法、及びキット
|
|
EP2512450B1
(de)
|
2009-12-15 |
2018-02-07 |
Ascendis Pharma Endocrinology Division A/S |
Transient an polymerträger gekoppelte trockene wachstumshormonzusammensetzungen
|
|
EA201290541A1
(ru)
|
2009-12-21 |
2013-05-30 |
Амбркс, Инк. |
Модифицированные бычьи соматотропиновые полипептиды и их применение
|
|
JP2013515081A
(ja)
|
2009-12-21 |
2013-05-02 |
アンブルックス,インコーポレイテッド |
修飾されているブタのソマトトロピンポリペプチドおよびそれらの使用
|
|
AR079344A1
(es)
|
2009-12-22 |
2012-01-18 |
Lilly Co Eli |
Analogo peptidico de oxintomodulina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar diabetes no insulinodependiente y/u obesidad
|
|
JO2976B1
(en)
|
2009-12-22 |
2016-03-15 |
ايلي ليلي اند كومباني |
Axentomodulin polypeptide
|
|
ES2905545T3
(es)
|
2010-01-06 |
2022-04-11 |
Takeda Pharmaceuticals Co |
Proteínas de unión a calicreína plasmática
|
|
EP2525831B1
(de)
|
2010-01-22 |
2019-05-15 |
Ascendis Pharma A/S |
Trägerverknüpfte carbamat-prodrug-linker
|
|
WO2011140393A1
(en)
*
|
2010-05-05 |
2011-11-10 |
Prolynx Llc |
Controlled release from macromolecular conjugates
|
|
DK2595624T3
(en)
|
2010-07-20 |
2018-03-26 |
Halozyme Inc |
Methods of treating or preventing adverse side effects associated with administration of an anti-hyaluronan agent
|
|
TWI534152B
(zh)
|
2010-07-30 |
2016-05-21 |
巴克斯特國際公司 |
用於肟連接的親核性催化劑
|
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
|
PE20140160A1
(es)
|
2010-08-17 |
2014-02-08 |
Ambrx Inc |
Polipeptidos de relaxina modificados y sus usos
|
|
EP2438930A1
(de)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Prodrug mit einem exendinbindenden Konjugat
|
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
|
SI2621496T2
(sl)
|
2010-09-30 |
2019-04-30 |
Astrazeneca Ab |
Kristalinični konjugat naloksol-PEG
|
|
WO2012054822A1
(en)
|
2010-10-22 |
2012-04-26 |
Nektar Therapeutics |
Pharmacologically active polymer-glp-1 conjugates
|
|
WO2012054861A1
(en)
|
2010-10-22 |
2012-04-26 |
Nektar Therapeutics |
Glp-1 polymer conjugates having a releasable linkage
|
|
ES2800983T3
(es)
|
2010-12-22 |
2021-01-07 |
Baxalta GmbH |
Materiales y métodos para conjugar un derivado de ácido graso soluble en agua con una proteína
|
|
US20120196933A1
(en)
*
|
2010-12-23 |
2012-08-02 |
Richard Franklin |
Mexiletine prodrugs
|
|
KR102011156B1
(ko)
|
2011-01-06 |
2019-08-16 |
다이액스 코포레이션 |
혈장 칼리크레인 결합 단백질
|
|
US8440309B2
(en)
|
2011-01-31 |
2013-05-14 |
Confluent Surgical, Inc. |
Crosslinked polymers with the crosslinker as therapeutic for sustained release
|
|
EP2907504B1
(de)
|
2011-02-08 |
2017-06-28 |
Halozyme, Inc. |
Zusammensetzung und Lipidformulierung eines Hyaluronan-abbauenden Enzyms und seiner Verwendung zur Behandlung von benigner Prostatahyperplasie
|
|
EP3412314A1
(de)
|
2011-05-27 |
2018-12-12 |
Baxalta GmbH |
Mit polysialsäure konjugierte therapeutische proteine und verfahren zur herstellung davon
|
|
US20130022592A1
(en)
|
2011-06-17 |
2013-01-24 |
Daniel Edward Vaughn |
Continuous subcutaneous insulin infusion methods with a hyaluronan-degrading enzyme
|
|
US9993529B2
(en)
|
2011-06-17 |
2018-06-12 |
Halozyme, Inc. |
Stable formulations of a hyaluronan-degrading enzyme
|
|
EP2741779A1
(de)
|
2011-08-12 |
2014-06-18 |
Ascendis Pharma A/S |
Hochbeladene wasserlösliche trägerstoffvernetzte prodrugs
|
|
HK1198628A1
(en)
|
2011-08-12 |
2015-05-22 |
Ascendis Pharma A/S |
Polymeric hyperbranched carrier-linked prodrugs
|
|
US20140323402A1
(en)
|
2011-08-12 |
2014-10-30 |
Ascendis Phama A/S |
Protein Carrier-Linked Prodrugs
|
|
US20130071394A1
(en)
|
2011-09-16 |
2013-03-21 |
John K. Troyer |
Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and methods of use
|
|
MX2014003993A
(es)
|
2011-10-12 |
2014-08-08 |
Ascendis Pharma Ophthalmology Division As |
Prevencion y tratamiento de condiciones oculares.
|
|
CA2853358A1
(en)
|
2011-10-24 |
2013-05-02 |
Halozyme, Inc. |
Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
|
|
SG11201403714TA
(en)
|
2011-12-30 |
2014-07-30 |
Halozyme Inc |
Ph20 polypeptide variants, formulations and uses thereof
|
|
EP2833905B1
(de)
|
2012-04-04 |
2018-05-02 |
Halozyme, Inc. |
Kombinationbehnadlung von hyaluronidase und einem tumor-gerichteten taxane
|
|
AU2013204754C1
(en)
|
2012-05-16 |
2018-10-11 |
Takeda Pharmaceutical Company Limited |
Nucleophilic Catalysts for Oxime Linkage
|
|
US9738724B2
(en)
|
2012-06-08 |
2017-08-22 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
EP3135690A1
(de)
|
2012-06-26 |
2017-03-01 |
Sutro Biopharma, Inc. |
Modifizierte fc-proteine mit stellenspezifischen nichtnatürlichen aminosäureresten, konjugate daraus, verfahren zu deren herstellung und verfahren zu deren verwendung
|
|
SI2890402T1
(sl)
|
2012-08-31 |
2019-07-31 |
Sutro Biopharma, Inc. |
Modificirane aminokisline vsebujoče acido skupino
|
|
MY186106A
(en)
|
2012-10-11 |
2021-06-22 |
Ascendis Pharma As |
Diagnosis, prevention and treatment of diseases of the joint
|
|
WO2014062856A1
(en)
|
2012-10-16 |
2014-04-24 |
Halozyme, Inc. |
Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
|
|
JP6358661B2
(ja)
*
|
2013-03-19 |
2018-07-18 |
公立大学法人首都大学東京 |
界面活性剤様化合物
|
|
TW201534726A
(zh)
|
2013-07-03 |
2015-09-16 |
Halozyme Inc |
熱穩定ph20玻尿酸酶變異體及其用途
|
|
WO2015006555A2
(en)
|
2013-07-10 |
2015-01-15 |
Sutro Biopharma, Inc. |
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
WO2015054658A1
(en)
|
2013-10-11 |
2015-04-16 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
|
WO2015081891A1
(en)
|
2013-12-06 |
2015-06-11 |
Baikang (Suzhou) Co., Ltd |
Bioreversable promoieties for nitrogen-containing and hydroxyl-containing drugs
|
|
IL247942B
(en)
|
2014-03-27 |
2022-09-01 |
Dyax Corp |
Compositions and methods for drops in macular edema as a result of diabetes
|
|
EP2949687B1
(de)
|
2014-05-29 |
2016-10-19 |
Dow Global Technologies Llc |
Wasserzuführverfahren zur steuerung der molekulargewichtsverteilung und von nebenprodukten der carbamylierung von harnstoff
|
|
EP3186281B1
(de)
|
2014-08-28 |
2019-04-10 |
Halozyme, Inc. |
Kombinationstherapie mit einer hyaluronanabbauendem enzym und einem immun-checkpoint-hemmer
|
|
AU2015332533B2
(en)
|
2014-10-14 |
2018-08-30 |
Halozyme, Inc. |
Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same
|
|
MX2017004947A
(es)
|
2014-10-24 |
2017-06-29 |
Bristol Myers Squibb Co |
Polipeptidos del factor de crecimiento de fibroblastos 2 (fgf-21) modificados y usos de los mismos.
|
|
KR102608645B1
(ko)
|
2014-11-18 |
2023-12-01 |
아센디스 파마 엔도크리놀로지 디비전 에이/에스 |
신규한 중합체성 hGH 프로드러그
|
|
EP4732848A3
(de)
|
2014-11-21 |
2026-07-29 |
Ascendis Pharma Endocrinology Division A/S |
Langwirkende wachstumshormondosierformen
|
|
US11286307B2
(en)
|
2015-12-11 |
2022-03-29 |
Takeda Pharmaceutical Company Limited |
Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
|
|
JP6925579B2
(ja)
*
|
2016-03-31 |
2021-08-25 |
日油株式会社 |
環状ベンジリデンアセタール構造を有する生分解性ヒドロゲル
|
|
JP6949102B2
(ja)
|
2016-08-09 |
2021-10-13 |
イーライ リリー アンド カンパニー |
併用療法
|
|
SG10201912034UA
(en)
|
2017-02-08 |
2020-02-27 |
Bristol Myers Squibb Co |
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
|
|
PE20200697A1
(es)
|
2017-06-22 |
2020-06-16 |
Catalyst Biosciences Inc |
Polipeptidos de serina proteasa 1 de tipo membrana modificada (mtsp-1) y metodos de uso
|
|
US11897917B2
(en)
|
2017-09-27 |
2024-02-13 |
The University Of York |
Bioconjugation of polypeptides
|
|
KR102777151B1
(ko)
|
2017-11-21 |
2025-03-05 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
인터루킨-2의 부분 효능제
|
|
WO2019222435A1
(en)
|
2018-05-16 |
2019-11-21 |
Halozyme, Inc. |
Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
|
|
KR20210057124A
(ko)
|
2018-09-11 |
2021-05-20 |
암브룩스, 인코포레이티드 |
인터류킨-2 폴리펩타이드 접합체 및 그의 용도
|
|
JP2022512746A
(ja)
|
2018-10-19 |
2022-02-07 |
アンブルックス,インコーポレイテッド |
インターロイキン-10ポリペプチド複合体、その二量体、およびそれらの使用
|
|
JP7604376B2
(ja)
|
2018-12-28 |
2024-12-23 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
改変ウロキナーゼ型プラスミノゲンアクティベータポリペプチドおよび使用方法
|
|
CN119455003A
(zh)
|
2019-02-12 |
2025-02-18 |
Ambrx公司 |
包含抗体-tlr激动剂缀合物的组合物、方法和用途
|
|
JP7524206B2
(ja)
|
2019-03-04 |
2024-07-29 |
アセンディス ファーマ エンドクライノロジー ディヴィジョン エー/エス |
1日ごとのソマトロピンよりも優れた効力を有する長時間作用性成長ホルモン剤形
|
|
MX2021011997A
(es)
*
|
2019-04-05 |
2021-11-04 |
Prolynx Llc |
Enlazadores de conjugacion mejorados.
|
|
AU2021209045A1
(en)
|
2020-01-13 |
2022-07-28 |
Takeda Pharmaceutical Company Limited |
Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack
|
|
CN115362168A
(zh)
|
2020-01-14 |
2022-11-18 |
辛德凯因股份有限公司 |
偏向化il2突变蛋白方法和组合物
|
|
EP4117732A1
(de)
|
2020-03-11 |
2023-01-18 |
Ambrx, Inc. |
Interleukin-2-polypeptidkonjugate und verfahren zur verwendung davon
|
|
WO2022040596A1
(en)
|
2020-08-20 |
2022-02-24 |
Ambrx, Inc. |
Antibody-tlr agonist conjugates, methods and uses thereof
|
|
WO2022212899A1
(en)
|
2021-04-03 |
2022-10-06 |
Ambrx, Inc. |
Anti-her2 antibody-drug conjugates and uses thereof
|
|
CN114209824B
(zh)
*
|
2021-11-09 |
2023-06-20 |
淮阴工学院 |
用于肿瘤渗透增强性光热与化疗联合使用的阿霉素前药及其制备方法
|
|
WO2025227129A2
(en)
|
2024-04-25 |
2025-10-30 |
Starrock Pharma Llc |
Delivery vehicles comprising proglucagon derived polypeptides and anabolic polypeptides and uses thereof
|
|
US20250341516A1
(en)
|
2024-05-01 |
2025-11-06 |
BioLegend, Inc. |
Compositions for use with multiple fluorophores and methods of using
|
|
WO2026043823A2
(en)
|
2024-08-19 |
2026-02-26 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific non-natural amino acid residues, methods of preparation and uses thereof
|
|
CN119219604B
(zh)
*
|
2024-09-25 |
2025-11-18 |
大连理工大学 |
一种吡啶季铵盐类fk866前药、其制备方法及应用
|